Intracerebroventricular SPAST-AAV9 gene therapy prevents manifestation of symptoms in a mouse model of SPG4 hereditary spastic paraplegia
December 19, 2025
Hereditary spastic paraplegia type 4 is characterized by gait impairments, progressive spasticity, and weakness of...